Romero-Hernández S, Saavedra-Uribe J, Zamarrón-López EI, Pérez-Nieto OR, Figueroa-Uribe AF, Guerrero-Gutiérrez MA, López-Fermín J, Uribe-Moya SE, Soriano-Orozco R, Morgado-Villaseñor LA, Flores-Ramírez R, Salmerón JD, Gasca-Aldama JC, Sánchez-Díaz JS, Deloya-Tomás E, Madrigal-Sánchez D, López-Pérez FJ, Villa-Cortés PG, Saucedo-Barrientos AL, Carrión-Moya JD, Castillo-Gutiérrez G, León-Fernández OD, Díaz-Martínez MA, Castillo-Altamirano TA, Mendieta-Carrera AN, Fuentes-Carraza PE, Cortés-Meza HM, Rodríguez-González EF

Language: Spanish
References: 7
Page: 3-10
PDF size: 901.71 Kb.

Text Extraction

No abstract.

REFERENCES

1. Ugarte C. Response to COVID-19 outbreak in the region of the Americas. PanAmerican Health Organization/World Health Organization Twenty-third Street, NW, Washington, D.C. 525. 2020/ 20037 202-974-3469 ugarteci@paho.org.

2. Zhao S, et al. Serial interval in determining the estimation of reproduction number of the novel coronavirus disease (COVID-19) during the early outbreak. J TravelMed 2020 Mar 12. pii: taaa033. doi: 10.1093/jtm/taaa033.

3. Sthep M. Coronavirus (COVID-19) Uptodate: FDA Focuses on Safety of Regilated Products. While Scaling Back Domestic Inspections Commissioner of food and Drugs –March 18,2020. Administration: Michael.felbertbaum@fda.hhs.gov.

4. Lineamiento para la atención de los pacientes con COVID- 19, 14 de febrero, Secretaría de Salud. Pág 18-19.

5. World Health Organization. Novel Coronavirus (2019- nCoV) technical guidance. Disponible en: https://www. who.int/emergencies/diseases/novel-coronavirus-2019/ technical-guidance.

6. Usman OA, Usman AA, Ward MA. Comparison of SIRS, qSOFA, and NEWS for the early identification of sepsis in the Emergency Department. Am J Emerg Med 2019;37(8):1490-97.

7. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect. 2020 feb doi: 10.1016/j. jhin.2020.01.022. Disponible en: https://www.ncbi.nlm. nih.gov/pubmed/32035997.